Relman-Weil Debate: Three Views (3 of 3)

I agree with Dr. Weil.1 In spite of the efficacy of purified medicinals, a new industry has taken root. It is direct use of natural products. Native American Indians did not understand their use of herbs and roots, but they did know what was helpful. That folklore is available today in health food stores. The Old Lady of Shropshire was not a scientist, but she surely was an astute observer of the effects of digitalis plants. Doctors today should find something useful here, even if the supportin

Written bySs Fishman
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I agree with Dr. Weil.1 In spite of the efficacy of purified medicinals, a new industry has taken root. It is direct use of natural products. Native American Indians did not understand their use of herbs and roots, but they did know what was helpful. That folklore is available today in health food stores. The Old Lady of Shropshire was not a scientist, but she surely was an astute observer of the effects of digitalis plants. Doctors today should find something useful here, even if the supporting data is epidemiological.

I agree with Dr. Relman. Taking a concoction of natural impurities into your stomach has got to be inefficient in terms of efficacy of an active ingredient. There may be a stomach condition preexisting, and you would prefer not to add more irritants and bulk. The basis of modern medicine is purified active agents and a measured dose. Just about ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies